EUVIMEDEUVIMED entdecken
Editorial

Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting

Daniel J Olivieri iD, Rahul Banerjee iD

JCO Oncology Practice · 2025-05 · 21 (5) · 596-598

DOI: 10.1200/op-24-00921 ↗

Kurz gefasst

Editorial in der Zeitschrift JCO Oncology Practice, 2025-05. Verfasst von Daniel J Olivieri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, WA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle, WA.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.

ORCID-Profile: Daniel J Olivieri, Rahul Banerjee

Zitieren

APA

Olivieri, D. J., & Banerjee, R. (2025). Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting. JCO Oncology Practice, 21(5), 596-598. https://doi.org/10.1200/op-24-00921

Vancouver

Olivieri DJ, Banerjee R. Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting. JCO Oncology Practice. 2025;21(5):596-598. doi:10.1200/op-24-00921

BibTeX
@article{Olivieri2025,
  author = {Olivieri, Daniel J and Banerjee, Rahul},
  title = {Impatient for Outpatient: Operationalizing Bispecific Antibodies for Multiple Myeloma in the Ambulatory Setting},
  journal = {JCO Oncology Practice},
  year = {2025},
  volume = {21},
  number = {5},
  pages = {596--598},
  doi = {10.1200/op-24-00921}
}
Kostenlos starten →